Future studies of this fusion will hopefully elucidate how frequently it occurs in pediatric thyroid cancer, and if it could influence the global expressional output in PTCs in a similar manner as bona fide fusions involving NTRK or RET. However, it should be stated that our clustering analysis is based on a small sample series, and therefore validations in larger clinical series is warranted. This evidence concerns the gene RET and thyroid cancer.